Invention Grant
- Patent Title: Imidazopyridazinecarbonitriles useful as kinase inhibitors
- Patent Title (中): 咪唑哒嗪甲腈可用作激酶抑制剂
-
Application No.: US14191861Application Date: 2014-02-27
-
Publication No.: US09371328B2Publication Date: 2016-06-21
- Inventor: Brian E. Fink , Libing Chen , Ashvinikumar V. Gavai , Liqi He , Soong-Hoon Kim , Andrew James Nation , Yufen Zhao , Litai H. Zhang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D498/04
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US20140179674A1 IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS Public/Granted day:2014-06-26
Information query
